Figure 1d.
Event-free survival of patients according to gene expression profiling (GEP)-defined risk and the presence or absence of CA in both random sites and focal lesion sites (RS+/FL+). High-risk designation only lowers event-free survival expectations in 22 among the 236 patients lacking RS+/FL+ (“Not RS+/FL+”).